NON-SQUAMOUS NON SMALL CELL LUNG CANCER
Clinical trials for NON-SQUAMOUS NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-SQUAMOUS NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NON-SQUAMOUS NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
AI-Designed vaccine takes on tough lung cancer
Disease control ENROLLING_BY_INVITATIONThis study tests a personalized vaccine called Microlyvaq™ for people with advanced non-small cell lung cancer. The vaccine is custom-made for each patient using AI and computer modeling to target their unique tumor. It is given alongside standard chemotherapy and immunotherapy t…
Matched conditions: NON-SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: EARLY_PHASE1 • Sponsor: Biogenea Pharmaceuticals Ltd. • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New hope for lung cancer patients who stop responding to standard therapy
Disease control OngoingThis study tests whether adding the experimental drug AK112 to standard chemotherapy can help people with a specific type of advanced lung cancer (EGFR-mutant non-squamous NSCLC) live longer without their cancer growing. Participants have already tried and failed an EGFR-targeted…
Matched conditions: NON-SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Akeso • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New drug cocktail shows promise for tough lung cancer
Disease control OngoingThis study tests a combination of three drugs (tiragolumab, atezolizumab, and bevacizumab) in people with advanced non-squamous non-small-cell lung cancer that has already been treated. The goal is to see if this mix can shrink tumors or slow the disease. About 29 adults with spe…
Matched conditions: NON-SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 01, 2026 16:00 UTC